Phase3 trial comparing oral S-1 plus carboplatin with paclitaxel plus carboplatin in chemotherapy-naive patients with advanced non-small-cell lung cancer LETS Biomarker study
Not Applicable
- Conditions
- Previously untreated stage IIIB/IV NSCLC
- Registration Number
- JPRN-UMIN000006122
- Lead Sponsor
- West Japan Oncology Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 300
Inclusion Criteria
Not provided
Exclusion Criteria
Nothing particular
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Protein and gene expression analysis Somatic mutation analysis Gene amplification analysis
- Secondary Outcome Measures
Name Time Method